封面
市場調查報告書
商品編碼
1715680

疼痛管理設備市場按設備類型、應用程式、分銷管道、最終用戶和購買類型分類-2025-2030 年全球預測

Pain Management Devices Market by Device Type, Application, Distribution Channel, End User, Mode of Purchase - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計疼痛管理設備市場規模在 2023 年將達到 33.7 億美元,2024 年將成長至 36.5 億美元,複合年成長率為 8.79%,到 2030 年將達到 60.8 億美元。

主要市場統計數據
基準年2023年 33.7億美元
預計2024年 36.5億美元
預測年份 2030 60.8億美元
複合年成長率(%) 8.79%

在當今不斷發展的醫療保健領域,疼痛管理設備已成為患有各種疼痛相關疾病的患者護理連續性的重要支柱。該市場的特點是技術的快速進步、慢性疼痛和術後疼痛的日益普遍以及對傳統藥物干預替代品的需求日益成長。在深度研發投入和臨床合作的推動下,設備技術的創新正在重塑醫療保健提供者處理疼痛管理的方式。這項變化不僅提高了患者的安全性和治療效果,而且還為製造商和醫療機構創造了新的收益來源。

電刺激、磁療和射頻消融設備等先進治療方法的引入正在徹底改變傳統的疼痛管理通訊協定。隨著世界各地的醫療保健系統努力應對人口老化和慢性病增多的複雜挑戰,對非侵入性和微創疼痛管理解決方案的依賴變得越來越突出。此外,數位健康產品和連網型設備的整合為臨床醫生提供了改進的病患監測和個人化治療途徑,增強了這個細分市場的重要性。

該報告對當前趨勢、突破性技術和市場促進因素進行了深入分析,這些因素將影響疼痛管理設備在各種臨床環境中的採用。該分析重點關注該領域的現有公司和新興企業公司,為決策者提供對市場動態和未來成長潛力的全面了解。

改變疼痛管理設備市場

近年來,疼痛管理領域已從傳統的治療方法轉變為更為複雜的技術主導的解決方案。一個顯著的趨勢是產品系列的演變,製造商加大對提供精確度、更強控制力和改善患者治療效果的設備的投資。這種演變的突出表現是從基本的機械疼痛緩解系統轉向整合連接功能、遠端監控和改進的易用性的先進數位設備。

技術創新持續推動更全面的疼痛管理解決方案的發展。臨床醫生現在普遍使用的設備不僅可以解決疼痛根源,還可以提供診斷回饋和數據分析,以改善每位患者的治療方法。此外,微處理器技術的結合可以實現更細緻的治療,例如可變強度的電刺激和客製化射頻療法,從而提高這些治療方法的功效和安全性。監管機構簡化核准流程以適應醫療設備技術的突破、加速市場推出和臨床應用,進一步推動了這種動態演變。

另一個重大變化是人們對個人化醫療的興趣日益濃厚。感測器技術和穿戴式裝置的進步促進了即時回饋和患者數據的整合,從而可以根據患者的反應不斷最佳化治療策略。隨著醫療保健提供者繼續更加重視基於價值的護理模式,對能夠提供持續、可衡量的生活品質改善的設備的需求預計只會越來越強烈。這強調了行業內公司的戰略要務,即不斷創新並使其解決方案與臨床醫生和患者不斷變化的需求保持一致。

疼痛管理設備關鍵細分市場分析

對市場區隔的詳細分析揭示了有助於全面了解疼痛管理設備市場的幾個關鍵層面。按設備類型細分,我們會看到一系列技術,包括止痛藥輸液幫浦、電刺激設備、磁療設備和射頻消融術設備。例如,鎮痛輸液泵細分為鞘內泵和患者自控鎮痛泵,電刺激設備包括微電流治療儀、神經肌肉電刺激設備和經皮電神經刺激設備。同樣,射頻消融分為雙極、單極和脈衝,每種都有不同的臨床益處。

從應用角度來看,市場細分為癌症疼痛管理、月經疼痛管理、肌肉骨骼疼痛管理、神經病變疼痛管理、術後疼痛管理等。在肌肉骨骼疼痛領域,它進一步分為關節炎疼痛和腰痛;在術後疼痛管理中,它分為急性術後疼痛和慢性疼痛。這種細分凸顯了疼痛管理設備的多功能性,可以解決各種臨床情況,每種情況都能滿足獨特的患者需求。

按銷售管道細分,區分線下和線上,突出不斷變化的患者購買行為和變化的銷售策略。最終用戶細分進一步根據護理環境分類市場,例如居家照護、醫院/診所和長期護理中心。居家照護分為慢性病家庭護理和術後居家照護,而醫院和診所則分為中立診所和疼痛診所。長期照護中心進一步分為臨終關懷醫院和療養院,各自反映了各自的營運需求和病患群體。最後,將購買模式細分為非處方藥和處方藥管道,突顯了推動或抑制市場成長的監管和消費行為方面。

這種多層次的細分框架不僅突顯了疼痛管理設備市場的多樣性,還可以根據特定患者的需求制定客製化策略,最佳化分銷管道並增強產品供應。從這種細分中獲得的見解將有利於相關人員制定有針對性的行銷策略並在競爭環境中簡化其產品開發平臺。

目錄

第1章 引言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 運動傷害和整形外科疾病的增加推動了針對性疼痛緩解的需求
      • 患者越來越偏好個人化、家庭疼痛管理治療
      • 全球範圍內慢性疼痛的增加和技術創新正在推動對疼痛管理設備的需求。
    • 限制因素
      • 技術限制阻礙了疼痛管理設備的採用和有效性
    • 機會
      • 利用人工智慧和機器學習來提高疼痛管理設備解決方案的有效性
      • 利用遠端醫療整合擴大疼痛管理設備的使用範圍
    • 任務
      • 克服疼痛管理設備市場不斷變化的監管挑戰的策略方法
  • 市場區隔分析
    • 裝置類型:射頻消融術(RFA) 裝置作為疼痛管理的微創選擇,其需求量越來越大。
    • 應用:增加神經病變疼痛管理中疼痛管理設備在慢性疼痛管理的使用
    • 分銷管道:年輕一代、精通科技的一代擴大採用線上平台來銷售疼痛管理設備
    • 最終用戶:消費者對家庭醫療保健解決方案的偏好日益成長
    • 如何購買:非處方疼痛管理設備輔助預防性醫療保健解決方案的消費趨勢
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社會
    • 技術的
    • 合法的
    • 環境

6. 疼痛管理設備市場(依設備類型)

  • 止痛藥輸液泵
    • 椎管內泵
    • 病人自控鎮痛泵
  • 電刺激設備
    • 微電流治療 E-Stim 設備
    • 神經肌肉電刺激
    • 經皮電刺激
  • 磁療儀
  • 射頻消融術裝置
    • 雙極射頻消融
    • 單極射頻消融
    • 脈衝射頻消融

第7章疼痛管理設備市場(按應用)

  • 癌症疼痛管理
  • 月經疼痛管理
  • 肌肉骨骼疼痛管理
    • 關節炎疼痛
    • 下背部疼痛
  • 神經病變疼痛管理
  • 術後疼痛管理
    • 急性術後疼痛
    • 慢性手術疼痛

8. 疼痛管理設備市場(依通路)

  • 離線
  • 線上

第9章疼痛管理設備市場(依最終用戶分類)

  • 居家照護環境
    • 慢性病居家照護
    • 術後居家護理
  • 醫院和診所
    • 中立診所
    • 疼痛診所
  • 長期照護中心
    • 安寧療護
    • 養老院

第 10 章疼痛管理設備市場(按購買方式)

  • 在商店
  • 處方箋藥

11.美洲疼痛管理設備市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

12.亞太疼痛管理設備市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

13. 歐洲、中東和非洲疼痛管理設備市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023年市場佔有率分析
  • 2023年FPNV定位矩陣
  • 競爭情境分析
  • 戰略分析與建議

公司名單

  • Abbott Laboratories
  • AVACEN, Inc.
  • Avanos Medical, Inc.
  • B. Braun SE
  • BioElectronics Corporation
  • Boston Scientific Corporation
  • CEFALY Technology
  • Enovis Corporation
  • Healthmate International, LLC
  • HMS Medical Systems
  • ICU Medical, Inc.
  • iTENS, LLC
  • Johari Digital
  • Kimberly-Clark Corporation
  • Medtronic PLC
  • Multi Radiance Medical, Inc.
  • NeuroMetrix, Inc.
  • Nevro Corp.
  • OMRON Healthcare, Inc.
  • Oska Wellness
  • Pain Care Labs
  • Pain Management Technologies, Inc.
  • Pfizer, Inc.
  • Sanofi SA
  • Stryker Corporation
  • Ultracare Pro by Zealmax Innovations Pvt. Ltd.
  • Zynex, Inc.
Product Code: MRR-ED54C46E8320

The Pain Management Devices Market was valued at USD 3.37 billion in 2023 and is projected to grow to USD 3.65 billion in 2024, with a CAGR of 8.79%, reaching USD 6.08 billion by 2030.

KEY MARKET STATISTICS
Base Year [2023] USD 3.37 billion
Estimated Year [2024] USD 3.65 billion
Forecast Year [2030] USD 6.08 billion
CAGR (%) 8.79%

In today's evolving medical landscape, pain management devices have emerged as a critical pillar in the treatment continuum for patients suffering from various pain-related conditions. The market is defined by rapid advancements in technology, the increasing prevalence of chronic and post-operative pain, and a growing need for alternatives to traditional pharmacological interventions. Innovation in device technology, driven by deep R&D investments and clinical collaborations, is reshaping how healthcare providers approach pain management. This shift is not only enhancing patient safety and outcomes but is also offering new revenue streams for manufacturers and healthcare facilities alike.

The introduction of advanced therapies such as electrical stimulation, magnetic therapy, and radiofrequency ablation devices is transforming conventional pain management protocols. As healthcare systems globally contend with the complexities of an aging population and rising incidences of chronic illnesses, the reliance on non-invasive and minimally invasive pain management solutions becomes ever more pronounced. Furthermore, the integration of digital health offerings and connected devices provides clinicians with improved patient monitoring and personalized treatment pathways, reinforcing the importance of this market segment.

This report conducts an in-depth analysis of current trends, breakthrough technologies, and market drivers that are influencing the deployment of pain management devices across various clinical settings. With a focus on both established and emerging players in the field, the analysis provides decision-makers with a comprehensive understanding of the market dynamics and future growth potentials.

Transformative Shifts in the Pain Management Devices Landscape

Recent years have witnessed a series of transformative shifts in the landscape of pain management devices, catalyzing a departure from traditional treatment modalities to more sophisticated, technology-driven solutions. A marked trend is the evolution of product portfolios, with manufacturers increasingly investing in devices that offer precision, enhanced control, and improved patient outcomes. This evolution is underscored by a transition from rudimentary mechanical pain relief systems to advanced digital devices that integrate connectivity features, remote monitoring, and enhanced usability.

Technological innovation continues to drive the transition towards more integrated pain management solutions. Clinicians now commonly employ devices that not only address pain at its source but also provide diagnostic feedback and data analytics to refine therapy on a patient-specific basis. Moreover, the incorporation of microprocessor technologies has enabled devices to deliver nuanced therapies such as variable intensity electrical stimulation and tailored radiofrequency treatments, increasing both the efficacy and safety profile of these interventions. This dynamic evolution is further bolstered by regulatory bodies streamlining approval processes to accommodate breakthroughs in medical device technology, thus accelerating time-to-market and clinical adoption.

Another significant shift in the landscape is driven by a heightened focus on personalized care. Advancements in sensor technology and wearable devices facilitate real-time feedback and patient data integration, ensuring that treatment regimes are continually optimized based on patient response. As healthcare providers continue to emphasize value-based care models, the demand for devices that can deliver consistent, measurable improvements in quality of life is set to intensify. This underscores the strategic imperative for industry players to continuously innovate and align their solutions with the evolving needs of both clinicians and patients.

Key Segmentation Insights in Pain Management Devices

A detailed analysis of market segmentation reveals multiple critical layers that contribute to a comprehensive understanding of the pain management devices market. An examination based on device type uncovers a rich tapestry of technologies such as analgesic infusion pumps, electrical stimulation devices, magnetic therapy devices, and radiofrequency ablation devices. These categories are further nuanced; for example, analgesic infusion pumps are subdivided into intrathecal pumps and patient-controlled analgesia pumps, while electrical stimulation devices encompass microcurrent therapy devices, neuromuscular electrical stimulation, and transcutaneous electrical nerve stimulation. Similarly, the radiofrequency ablation segment divides into bipolar, monopolar, and pulsed techniques, each offering distinct clinical advantages.

When viewed from an application standpoint, the market stratifies into areas like cancer pain management, menstrual pain management, musculoskeletal pain management, neuropathic pain management, and post-operative pain management. In the musculoskeletal arena, the focus further divides into arthritis pain and back pain, while post-operative pain management differentiates between acute post-surgical pain and chronic surgical pain. This segmentation underscores the versatility of pain management devices in addressing a broad spectrum of clinical scenarios, each with unique patient requirements.

Additional segmentation by distribution channel distinguishes between offline and online modes, highlighting evolving patient purchasing behaviors and changing distribution strategies. The end user segmentation further delineates the market based on care settings, including home care, hospitals and clinics, and long-term care centers. Home care is dissected into chronic illness and post-surgery home care, whereas hospitals and clinics are differentiated into neutral clinics and pain clinics. Long-term care centers are further segmented into hospices and nursing homes, each reflecting unique operational demands and patient populations. Lastly, the mode of purchase segmentation into over-the-counter and prescription-based channels illustrates the regulatory and consumer behavior dimensions that either facilitate or constrain market growth.

This multi-layered segmentation framework not only highlights the diversity within the pain management devices market but also enables players to tailor their strategies to target specific patient needs, optimize distribution channels, and enhance product offerings. The insights drawn from this segmentation are instrumental for stakeholders aiming to develop targeted marketing initiatives and to streamline product development pipelines in a competitive landscape.

Based on Device Type, market is studied across Analgesic Infusion Pumps, Electrical Stimulation Devices, Magnetic Therapy Devices, and Radiofrequency Ablation Devices. The Analgesic Infusion Pumps is further studied across Intrathecal Pumps and Patient-Controlled Analgesia Pumps. The Electrical Stimulation Devices is further studied across Microcurrent Therapy E-Stim Devices, Neuromuscular Electrical Stimulation, and Transcutaneous Electrical Nerve Stimulation. The Radiofrequency Ablation Devices is further studied across Bipolar RF Ablation, Monopolar RF Ablation, and Pulsed RF Ablation.

Based on Application, market is studied across Cancer Pain Management, Menstrual Pain Management, Musculoskeletal Pain Management, Neuropathic Pain Management, and Post-Operative Pain Management. The Musculoskeletal Pain Management is further studied across Arthritis Pain and Back Pain. The Post-Operative Pain Management is further studied across Acute Post-Surgical Pain and Chronic Surgical Pain.

Based on Distribution Channel, market is studied across Offline and Online.

Based on End User, market is studied across Home Care Settings, Hospitals And Clinics, and Long-Term Care Centers. The Home Care Settings is further studied across Chronic Illness Home Care and Post-Surgery Home Care. The Hospitals And Clinics is further studied across Neutral Clinics and Pain Clinics. The Long-Term Care Centers is further studied across Hospices and Nursing Homes.

Based on Mode of Purchase, market is studied across Over-the-counter and Prescription-based.

Regional Insights in the Global Pain Management Devices Market

The global market exhibits distinct regional nuances that significantly impact growth trajectories and investment opportunities. In the Americas, particularly within the United States and Canada, the mature healthcare infrastructure combined with high healthcare expenditure and an aging population has led to robust growth in the adoption of advanced pain management devices. Regions in the Americas are characterized by extensive clinical research, favorable reimbursement policies, and a high acceptance of innovative medical technologies. This has paved the way for rapid clinical integration and widespread use of sophisticated therapies that optimize patient outcomes.

Moving to Europe, the Middle East, and Africa, a blend of diverse healthcare systems and regulatory environments presents both challenges and opportunities. European countries, with their stringent regulatory frameworks and early adoption of cutting-edge healthcare solutions, serve as a bellwether for market trends, while emerging markets in the Middle East and Africa are beginning to harness innovative technologies to improve pain management. These regions are increasingly investing in healthcare infrastructure, driven by rising demand and the need to address chronic and post-operative pain in a cost-effective manner. The gradual harmonization of medical standards across these geographically and economically diverse regions is expected to foster a conducive environment for the accelerated adoption of advanced pain management solutions.

In the Asia-Pacific, dynamic economic growth, rapid urbanization, and increasing healthcare awareness are propelling the demand for pain management devices. Countries within this region are witnessing a surge in investments in healthcare technology, with a focus on integrating state-of-the-art devices that address both acute and chronic pain conditions. The region's market is particularly notable for its emphasis on cost-effective and scalable solutions that can cater to both high-end hospital settings and home-based care. This combination of affordability, improved accessibility, and technological innovation is setting the stage for significant market expansion in the coming years.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Competitive Landscape and Key Company Insights

A robust competitive environment defines the pain management devices market, with a mix of multinational corporations and agile innovators continually shaping market dynamics. Industry leaders such as Abbott Laboratories, AVACEN, Inc., and Avanos Medical, Inc. have demonstrated unwavering commitment to clinical excellence and technological innovation. Companies like B. Braun SE and BioElectronics Corporation are recognized for their advanced portfolio of products that cater to a diverse range of clinical applications, effectively addressing the multifaceted needs of pain management.

Notable players, including Boston Scientific Corporation and CEFALY Technology, have carved out a niche by delivering solutions that fuse cutting-edge technology with precise clinical performance. Other key companies such as Enovis Corporation and Healthmate International, LLC are pioneering developments that enhance patient comfort and provide data-driven insights to clinicians. HMS Medical Systems, ICU Medical, Inc., and iTENS, LLC have reinforced their market positions by introducing devices that offer superior reliability and adaptability in various clinical settings.

The competitive landscape is further enriched by innovators like Johari Digital and Kimberly-Clark Corporation, who continue to expand their footprint in the pain management arena through strategic initiatives and product diversification. Medtronic PLC and Multi Radiance Medical, Inc. contribute to the market's growth by investing significantly in research and development, consistently driving technological advancements. Companies such as NeuroMetrix, Inc. and Nevro Corp. have made notable strides in leveraging neuromodulation therapies to enhance pain relief effectiveness.

Other influential players, including OMRON Healthcare, Inc. and Oska Wellness, have augmented their portfolios with specialized devices that offer targeted pain relief solutions. Emerging companies like Pain Care Labs and Pain Management Technologies, Inc. are also gaining traction by addressing niche market segments with innovative approaches. Industry giants like Pfizer, Inc., Sanofi S.A., and Stryker Corporation round out the competitive landscape by combining extensive research capabilities with expansive distribution networks, thereby ensuring a consistent pipeline of next-generation devices. Likewise, Ultracare Pro by Zealmax Innovations Pvt. Ltd. and Zynex, Inc. continue to push the envelope with novel therapeutic technologies that address both acute and chronic pain conditions. The sustained focus on innovation and quality underscores the market's commitment to delivering effective and safe pain management solutions, cementing the role of these key players in shaping future trends.

The report delves into recent significant developments in the Pain Management Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AVACEN, Inc., Avanos Medical, Inc., B. Braun SE, BioElectronics Corporation, Boston Scientific Corporation, CEFALY Technology, Enovis Corporation, Healthmate International, LLC, HMS Medical Systems, ICU Medical, Inc., iTENS, LLC, Johari Digital, Kimberly-Clark Corporation, Medtronic PLC, Multi Radiance Medical, Inc., NeuroMetrix, Inc., Nevro Corp., OMRON Healthcare, Inc., Oska Wellness, Pain Care Labs, Pain Management Technologies, Inc., Pfizer, Inc., Sanofi S.A., Stryker Corporation, Ultracare Pro by Zealmax Innovations Pvt. Ltd., and Zynex, Inc.. Actionable Recommendations for Industry Leaders

In light of the evolving competitive dynamics and market segmentation insights, industry leaders are advised to adopt a multi-pronged strategy that encompasses both innovation and strategic collaboration. Investing in research and development to enhance product efficacy and safety remains paramount, particularly in exploring advanced device functionalities that integrate digital monitoring and data analytics. Decision-makers should also consider diversifying product portfolios to address the nuanced requirements underscored by varying device types, applications, and care settings. Such a diversified approach not only positions companies to capture emerging market segments but also mitigates risks associated with the rapid pace of technological disruption.

To stay ahead in an increasingly competitive environment, companies should strategically harness insights from regional market trends. Embracing a localized strategy that caters to the specific regulatory, economic, and cultural landscapes of regions such as the Americas, Europe, the Middle East & Africa, and Asia-Pacific will foster greater market penetration. This requires a blend of targeted marketing efforts, tailored product offerings, and flexible pricing strategies that resonate with localized demand. Emphasis should also be placed on enhancing distribution channels, including leveraging both online and offline methodologies, to ensure wider market access and improved customer engagement.

Collaboration with academic institutions and key opinion leaders can yield valuable insights that guide innovation and clinical validation. Such partnerships not only bolster the credibility of new technologies but also facilitate quicker adoption within clinical practices. Additionally, aligning with regulatory bodies and industry associations may provide the necessary support to navigate complex market dynamics and to expedite the approval process for breakthrough pain management devices.

Furthermore, a robust post-market surveillance system is essential to track device performance and gather real-world evidence, enabling the continuous refinement of therapeutic solutions. This iterative approach, combined with strategic investments in digital health ecosystems, will empower companies to provide value-added services that extend beyond the initial sale of devices. By integrating telemedicine and remote monitoring capabilities, companies can enhance patient support, optimize therapeutic regimens, and drive long-term consumer satisfaction.

Overall, the recommended approach entails building a resilient and agile operational framework that embraces technological innovations, fosters strategic partnerships, and adapts to shifting market dynamics. This will not only secure a competitive edge in the ever-evolving landscape but also ensure sustainable growth and improved patient outcomes.

Conclusion: Charting a New Course in Pain Management

In summary, the pain management devices market is on the cusp of transformative growth, driven by rapid technological innovation and evolving clinical needs. The multifaceted segmentation across device type, application, distribution channel, end user, and mode of purchase highlights the diversity of demand and the opportunities to customize solutions for varied patient populations. This dynamic landscape, further enriched by regional economic trends and competitive innovation, underscores the imperative for industry leaders to remain agile, invest in advanced technologies, and foster collaborative ecosystems.

The insights presented demonstrate that a forward-thinking approach, one that blends robust R&D with localized strategies and enhanced digital offerings, is essential for sustaining market momentum. As the industry continues to evolve, a clear emphasis on personalized, data-driven, and patient-centric solutions will be the cornerstone of success in chronic and acute pain management. With pressing clinical demands and significant potential for improved patient outcomes, stakeholders are encouraged to leverage these insights to position themselves at the forefront of this innovative field.

Looking ahead, the confluence of clinical precision, technological advancements, and strategic market insights presents a compelling narrative for future investment and growth. The path forward is defined by continuous innovation, strategic agility, and an unwavering commitment to enhancing patient care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in sports injuries and orthopedic conditions amplifying demand for targeted pain relief
      • 5.1.1.2. Increasing patient preference for personalized and home-based pain management therapies
      • 5.1.1.3. Growing demand for pain management devices driven by global rise in chronic pain prevalence and technological innovations
    • 5.1.2. Restraints
      • 5.1.2.1. Technological limitations hampers adoption and effectiveness of pain management devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Utilizing AI and machine learning to enhance the effectiveness of pain management device solutions
      • 5.1.3.2. Leveraging telehealth integration to expand pain management device accessibility
    • 5.1.4. Challenges
      • 5.1.4.1. Strategic approaches to overcome regulatory challenges in the evolving pain management devices market
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Increasing demand for radiofrequency ablation (RFA) devices due to their minimally invasive options for pain management
    • 5.2.2. Application: Proliferating use of pain management devices in neuropathic pain management for chronic pain management
    • 5.2.3. Distribution Channel: Growing adoption of online platforms for pain management devices by young, tech-savy generation
    • 5.2.4. End User: Rising consumer preference for at-home healthcare solutions
    • 5.2.5. Mode of Purchase: OTC pain management devices complement consumer trends toward preventative healthcare solutions
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Pain Management Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. Analgesic Infusion Pumps
    • 6.2.1. Intrathecal Pumps
    • 6.2.2. Patient-Controlled Analgesia Pumps
  • 6.3. Electrical Stimulation Devices
    • 6.3.1. Microcurrent Therapy E-Stim Devices
    • 6.3.2. Neuromuscular Electrical Stimulation
    • 6.3.3. Transcutaneous Electrical Nerve Stimulation
  • 6.4. Magnetic Therapy Devices
  • 6.5. Radiofrequency Ablation Devices
    • 6.5.1. Bipolar RF Ablation
    • 6.5.2. Monopolar RF Ablation
    • 6.5.3. Pulsed RF Ablation

7. Pain Management Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer Pain Management
  • 7.3. Menstrual Pain Management
  • 7.4. Musculoskeletal Pain Management
    • 7.4.1. Arthritis Pain
    • 7.4.2. Back Pain
  • 7.5. Neuropathic Pain Management
  • 7.6. Post-Operative Pain Management
    • 7.6.1. Acute Post-Surgical Pain
    • 7.6.2. Chronic Surgical Pain

8. Pain Management Devices Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
  • 8.3. Online

9. Pain Management Devices Market, by End User

  • 9.1. Introduction
  • 9.2. Home Care Settings
    • 9.2.1. Chronic Illness Home Care
    • 9.2.2. Post-Surgery Home Care
  • 9.3. Hospitals And Clinics
    • 9.3.1. Neutral Clinics
    • 9.3.2. Pain Clinics
  • 9.4. Long-Term Care Centers
    • 9.4.1. Hospices
    • 9.4.2. Nursing Homes

10. Pain Management Devices Market, by Mode of Purchase

  • 10.1. Introduction
  • 10.2. Over-the-counter
  • 10.3. Prescription-based

11. Americas Pain Management Devices Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Pain Management Devices Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Pain Management Devices Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Strategic collaboration between CANNORDIC and Nimbus Health with CBD-infused pain management solutions
    • 14.3.2. Nevro's innovative AI-driven spinal cord stimulation technology for personalized pain management solutions
    • 14.3.3. Hinge Health's new wireless pain relief device expected to transform digital health market
    • 14.3.4. Zynex Medical expands portfolio with TensWave to address insurance gaps in growing neuromodulation narket
    • 14.3.5. Stryker's Strategic Acquisition of Vertos Medical to Boost Minimally Invasive Pain Management Solutions
    • 14.3.6. Stryker Introduces MultiGen 2 RF Generator in India to enhance chronic joint pain management
    • 14.3.7. Medtronic introduces Inceptiv SCS for advanced pain management
    • 14.3.8. NeuroOne launches innovative OneRF Ablation System to bolster market position
    • 14.3.9. Zynex expands pain management solutions with innovative hybrid spinal support and portable cold compression launch
    • 14.3.10. FDA approval of Boston Scientific's WaveWriter SCS Systems expands non-surgical back pain solutions
  • 14.4. Strategy Analysis & Recommendation
    • 14.4.1. Pfizer Inc.
    • 14.4.2. Stryker Corporation
    • 14.4.3. Medtronic PLC
    • 14.4.4. B. Braun SE
    • 14.4.5. Abbott Laboratories

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AVACEN, Inc.
  • 3. Avanos Medical, Inc.
  • 4. B. Braun SE
  • 5. BioElectronics Corporation
  • 6. Boston Scientific Corporation
  • 7. CEFALY Technology
  • 8. Enovis Corporation
  • 9. Healthmate International, LLC
  • 10. HMS Medical Systems
  • 11. ICU Medical, Inc.
  • 12. iTENS, LLC
  • 13. Johari Digital
  • 14. Kimberly-Clark Corporation
  • 15. Medtronic PLC
  • 16. Multi Radiance Medical, Inc.
  • 17. NeuroMetrix, Inc.
  • 18. Nevro Corp.
  • 19. OMRON Healthcare, Inc.
  • 20. Oska Wellness
  • 21. Pain Care Labs
  • 22. Pain Management Technologies, Inc.
  • 23. Pfizer, Inc.
  • 24. Sanofi S.A.
  • 25. Stryker Corporation
  • 26. Ultracare Pro by Zealmax Innovations Pvt. Ltd.
  • 27. Zynex, Inc.

LIST OF FIGURES

  • FIGURE 1. PAIN MANAGEMENT DEVICES MARKET MULTI-CURRENCY
  • FIGURE 2. PAIN MANAGEMENT DEVICES MARKET MULTI-LANGUAGE
  • FIGURE 3. PAIN MANAGEMENT DEVICES MARKET RESEARCH PROCESS
  • FIGURE 4. PAIN MANAGEMENT DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2023 VS 2030 (%)
  • FIGURE 17. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 21. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 26. PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 27. PAIN MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PAIN MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PAIN MANAGEMENT DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY INTRATHECAL PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PATIENT-CONTROLLED ANALGESIA PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MICROCURRENT THERAPY E-STIM DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROMUSCULAR ELECTRICAL STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MAGNETIC THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BIPOLAR RF ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MONOPOLAR RF ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PULSED RF ABLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CANCER PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MENSTRUAL PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ARTHRITIS PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY BACK PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUROPATHIC PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ACUTE POST-SURGICAL PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC SURGICAL PAIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY CHRONIC ILLNESS HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-SURGERY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NEUTRAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PAIN CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY PRESCRIPTION-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES PAIN MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 154. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 163. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 164. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 165. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 167. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 168. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 174. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 176. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 177. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 180. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 181. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 187. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 189. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 190. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 191. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 193. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 194. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 195. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 200. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 202. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 204. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 206. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 207. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 210. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 213. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 215. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 216. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 219. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 220. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 221. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 223. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 224. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 226. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 228. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 230. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 232. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 234. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 236. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 237. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 238. PHILIPPINES PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 239. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 241. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 242. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 244. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 245. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 246. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 247. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 248. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 249. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 250. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 251. SINGAPORE PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 252. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 254. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 256. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 258. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 260. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 262. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 263. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 264. SOUTH KOREA PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 265. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 267. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 268. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 269. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 270. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 271. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 272. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 273. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 275. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 276. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 277. TAIWAN PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 278. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 280. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 281. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 282. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 283. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 284. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 285. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 286. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 287. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 288. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 289. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 290. THAILAND PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 291. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 292. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 293. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 294. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2030 (USD MILLION)
  • TABLE 295. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 296. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY MUSCULOSKELETAL PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 297. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY POST-OPERATIVE PAIN MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 298. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 299. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOME CARE SETTINGS, 2018-2030 (USD MILLION)
  • TABLE 301. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2030 (USD MILLION)
  • TABLE 302. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY LONG-TERM CARE CENTERS, 2018-2030 (USD MILLION)
  • TABLE 303. VIETNAM PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2018-2030 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ANALGESIC INFUSION PUMPS, 2018-2030 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT DEVICES MARKET SIZE, BY ELECTRICAL STIMULATION DEVICES, 2018-2030 (USD MILL